FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors
about
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patientsEfficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.Mutational spectrum of adult T-ALLBCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiencyGenomic characterization of childhood acute lymphoblastic leukemia.Midostaurin for the treatment of acute myeloid leukemia.Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL.Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors.Molecular Features of Three Children Diagnosed With Early T-Cell Precursor Acute Lymphoblastic Leukemia.Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief ReportMixed-phenotypic acute leukemia: cytochemically myeloid and phenotypically early T-cell precursor acute lymphoblastic leukemiaCase report: Exome sequencing identifies T-ALL with myeloid features as a IKZF1-struck early precursor T-cell malignancy.An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia.The molecular mechanism behind resistance of the kinase FLT3 to the inhibitor quizartinib.Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing.Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.Different clones of acute leukemia after successful treatment of Hodgkin's disease.Acute lymphoblastic leukaemiaAcute lymphoblastic leukemia
P2860
Q33558120-D0391B89-C205-44D9-BD22-5FD38CF52B68Q34469099-2D14FBED-BE96-4E91-8E36-30D24084CFE8Q35171267-9423AA52-C498-40DB-831D-946441B7EC7CQ35550090-9D11A179-9183-412E-8E35-0245E1E9567AQ35690710-BA16F03B-C268-47FE-93CB-1C815358A429Q37026039-1390B557-C272-43E1-A910-8A89AD77C701Q37304113-9E9BB43E-ACB1-4610-B801-7080CC5B4EC6Q37359118-B407F9EA-3971-4E86-AF73-FB7597C324AAQ38671401-02D9103B-3471-4471-8971-EC34CF679721Q38744314-5D9BC19D-AF4B-4E62-9E0A-9995C67EAB12Q39041475-EABE793E-7611-4510-9FED-0CE7F1B193DFQ39443070-BE78FA50-B513-4BC9-A29D-1A08B83EC685Q40939605-6B29CAA7-D82F-491F-916C-16FDD980B7E1Q42019868-4D78D0DE-417A-4D7B-8A17-178A8605585FQ42069584-14F9E6CF-91FE-4BE5-AF6C-B59ABB70ACDBQ47155862-3C8496A3-5794-4008-823E-702C278AD68CQ47955491-80851B47-FD16-413D-87E9-16DCD59037F3Q47965368-56E01AC8-F6CA-4CB6-9666-E2DC3E49EFA3Q48186371-2C89C240-37DE-447C-AE69-AA035DC34826Q52371280-7D1BE93A-FB12-424B-A787-69D28E21994AQ52899841-EED5B092-9C79-44BD-90E1-C18891774A42Q54354801-A8792A8D-EEF5-4840-A2AB-BA29ED2A9A61Q58481753-4CB1F695-EFE7-4EFD-8EBA-477E05FCF6AAQ58481759-4AB8661F-510B-4C62-A1B3-F98F9B506600
P2860
FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@ast
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@en
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@nl
type
label
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@ast
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@en
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@nl
prefLabel
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@ast
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@en
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@nl
P2093
P2860
P50
P1433
P1476
FLT3 mutations in early T-cell ...... of tyrosine kinase inhibitors
@en
P2093
Christian Brandts
Claudia D Baldus
Cornelia Schlee
Dieter Hoelzer
Ebru Coskun
Eckhard Thiel
Isabelle Bartram
Lars Fransecky
Liliana H Mochmann
Martin Griesshammer
P2860
P304
P356
10.1371/JOURNAL.PONE.0053190
P407
P577
2013-01-24T00:00:00Z